In this issue, guest editors bring their considerable expertise to this important topic.
Key Features
Provides in-depth reviews on the latest updates in the field, providing actionable insights for clinical practice. Presents the latest information on this timely, focused topic under the leadership of experienced editors in the field. Authors synthesize and distill the latest research and practice guidelines to create these timely topic-based reviews.
Author Information
Edited by Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI, Director of Mount Sinai Heart, Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States and Ragavendra R. Baliga, MD, MBA, FACP, FRCP, FACC, Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical Center
Glucose-Lowering and Metabolic Effects of SGLT2 Inhibitors Renoprotective Effects of SGLT2 Inhibitors SGLT2 Inhibitors in Type 2 Diabetes Mellitus SGLT2 Inhibitors in Heart Failure with Reduced Ejection Fraction: A Paradigm Shift Toward Dual Cardio-Renal Protection SGLT2 Inhibitors and Heart Failure with Preserved Ejection Fraction SGLT2 Inhibitors in Heart Failure: Early Initiation to Achieve Rapid Clinical Benefits Sodium-Glucose Cotransporter-2 Inhibitors: Impact on Atherosclerosis and Atherosclerotic Cardiovascular Disease Events SGLT2 Inhibitors and Peripheral Vascular Events: A Review of the Literature Sodium-glucose Cotransporter 2 Inhibitors and Nonalcoholic Fatty Liver Disease SGLT2 Inhibitors and Safety in Older Patients Sodium Glucose Cotransporter 2 Inhibitors, Amputation Risk, and Fracture Risk
Bring it with you - The Bookshelf app allows you to access books on your laptop, tablet or mobile, so your ebooks go where ever you are - online or offline.
Take notes - Highlight, bookmark and take notes and highlights automatically stay in sync no matter where you make them.
Listen to eBooks - When you need to go screenless, the Text-to-speech tool will read your book aloud.
Powerful search - The searching capabilities allow you to search keywords through all your eBooks, the entire Bookshelf Library and well as on Wikipedia.
Ecological - Manage your environmental impact with paperless books.
How to read your VitalSource eBooks
Purchase your VitalSource eBook on the Elsevier Health site
https://www.mea.elsevierhealth.com/sglt-2-inhibitors-an-issue-of-heart-failure-clinics-9780323960465.html289638SGLT-2 Inhibitors, An Issue of Heart Failure Clinicshttps://www.mea.elsevierhealth.com/media/catalog/product/9/7/9780323960465_1.jpg71.1988.99USDInStock/Medicine and Surgery/Cardiology/Books/Clinics Review Articles99275255039561283813733745145120In this issue, guest editors bring their considerable expertise to this important topic. In this issue, guest editors bring their considerable expertise to this important topic.USD00add-to-cart97803239604652022ProfessionalEdited by Deepak L. Bhatt, MD, MPH, FACC, FAHA, FESC, MSCAI and Ragavendra R. Baliga, MD, MBA, FACP, FRCP, FACC20221Book178w x 254h (7.00" x 10.00")Elsevier24011 Oct 2022PRINT ON DEMAND - DELIVERY CAN TAKE UP TO 10 DAYSEdited by <STRONG>Deepak L. Bhatt</STRONG>, MD, MPH, FACC, FAHA, FESC, MSCAI, Director of Mount Sinai Heart, Dr. Valentin Fuster Professor of Cardiovascular Medicine, Icahn School of Medicine at Mount Sinai, New York, New York, United States and <STRONG>Ragavendra R. Baliga</STRONG>, MD, MBA, FACP, FRCP, FACC, Inaugural Director, Cardio-Oncology Center of Excellence Professor of Internal Medicine The Ohio State University Wexner Medical CenterClinicsThe Clinics: Internal MedicineNoNoNoNoPlease SelectPlease SelectPlease Select
